BrightSpring Health Services, Inc. Common Stock (NASDAQ: BTSG) is a Healthcare company (Medical - Healthcare Information Services) with a market capitalization of $13.8B. The Maz Rating grades it against the other companies in its sector.
About three months ago (July 2, 2026), BrightSpring Health Services, Inc. Common Stock had a Maz Rating of 4.82 out of 5 (A, Strong Buy), ranked against the other companies in its sector. Its strongest factor then was Momentum (4.79), among the strongest in its sector; its weakest was Valuation (1.77), more expensive than most of its sector. The other factors: Growth 4.77 (among the strongest in its sector); Profitability 4.59 (among the strongest in its sector); Financial Health 2.67 (around the middle of its sector). The current rating is for members: log in to see it.
At $69.15, BrightSpring Health Services, Inc. Common Stock trades at 42.2x trailing earnings, 0.9x sales and 6.6x book value, with an EV/EBITDA of 21.7. Over the last twelve months it generated about $15.2B of revenue and $326M of net income. It runs a gross margin of 12.5%, an operating margin of 3.6% and a net margin of 2.2%. It shows return on equity of 16.8%, return on invested capital of 9.8% and a free cash flow yield of 3.6%. On the balance sheet: a debt-to-equity ratio of 1.09 and a current ratio of 1.62. Over the past 52 weeks the share price ranged from $30.64 to $73.75, with a beta of 1.78.
BrightSpring Health Services, Inc. Common Stock does not currently pay a dividend.
13 Wall Street analyst ratings cover the stock: 13 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.